Atrial Fibrillation in Heart Failure Focus on Antithrombotic Management

被引：1
作者：
Obeidat, Mohammed [1 ]
Burgess, Malcolm [1 ]
Lip, Gregory Y. H. [2 ,3 ,4 ,5 ]
机构：
[1] Aintree Hosp, Dept Cardiol, Liverpool, England
[2] Univ Liverpool Liverpool, Liverpool Ctr Cardiovasc Sci, Liverpool, England
[3] Aalborg Univ, Dept Clin Med, Aalborg Thrombosis Res Unit, Aalborg, Denmark
[4] Liverpool Ctr Cardiovasc Sci, William Henry Duncan Bldg 6 West Derby St, Liverpool L7 8TX, England
[5] Chest Hosp, Liverpool, Merseyside, England
来源：
CARDIOLOGY CLINICS | 2022年 / 40卷 / 02期
关键词：
Atrial fibrillation; Heart failure; Anticoagulation; NOAC; Direct oral anticoagulant; PRESERVED EJECTION FRACTION; 2016 ESC GUIDELINES; ORAL ANTICOAGULANTS; PROGNOSTIC-SIGNIFICANCE; STROKE PREVENTION; CARDIAC STRUCTURE; ADVERSE OUTCOMES; NERVOUS-SYSTEM; WARFARIN; RISK;
D O I：
10.1016/j.ccl.2021.12.012
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：245 / 258
页数：14
相关论文
共 75 条
  • [21] Gronefeld Gerian C, 2003, J Cardiovasc Pharmacol Ther, V8, P107, DOI 10.1177/107424840300800203
  • [22] Guttmann OP, 2013, EUR HEART J, V34, P530
  • [23] Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation
    Hart, Robert G.
    Pearce, Lesly A.
    Aguilar, Maria I.
    [J]. ANNALS OF INTERNAL MEDICINE, 2007, 146 (12) : 857 - 867
  • [24] Neurohormonal activation in heart failure with reduced ejection fraction
    Hartupee, Justin
    Mann, Douglas L.
    [J]. NATURE REVIEWS CARDIOLOGY, 2017, 14 (01) : 30 - 38
  • [25] Hetherington M., 1985, EUR HEART J, V6, P1016
  • [26] PLATELET-FUNCTION, THROMBIN AND FIBRINOLYTIC-ACTIVITY IN PATIENTS WITH HEART-FAILURE
    JAFRI, SM
    OZAWA, T
    MAMMEN, E
    LEVINE, TB
    JOHNSON, C
    GOLDSTEIN, S
    [J]. EUROPEAN HEART JOURNAL, 1993, 14 (02) : 205 - 212
  • [27] Autonomic Remodeling in the Left Atrium and Pulmonary Veins in Heart Failure Creation of a Dynamic Substrate for Atrial Fibrillation
    Jason Ng
    Villuendas, Roger
    Cokic, Ivan
    Schliamser, Jorge E.
    Gordon, David
    Koduri, Hemanth
    Benefield, Brandon
    Simon, Julia
    Murthy, S. N. Prasanna
    Lomasney, Jon W.
    Wasserstrom, J. Andrew
    Goldberger, Jeffrey J.
    Aistrup, Gary L.
    Arora, Rishi
    [J]. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2011, 4 (03) : 388 - U209
  • [28] Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation With Hypertrophic Cardiomyopathy A Nationwide Cohort Study
    Jung, Hyunjean
    Yang, Pil-Sung
    Jang, Eunsun
    Yu, Hee Tae
    Kim, Tae-Hoon
    Uhm, Jae-Sun
    Kim, Jong-Youn
    Pak, Hui-Nam
    Lee, Moon-Hyoung
    Joung, Boyoung
    Lip, Gregory Y. H.
    [J]. CHEST, 2019, 155 (02) : 354 - 363
  • [29] Hypertrophic Cardiomyopathy in Patients with Atrial Fibrillation: Prevalence and Associated Stroke Risks in a Nationwide Cohort Study
    Jung, Hyunjean
    Yang, Pil-Sung
    Sung, Jung-Hoon
    Jang, Eunsun
    Yu, Hee Tae
    Kim, Tae-Hoon
    Uhm, Jae-Sun
    Kim, Jong-Youn
    Pak, Hui-Nam
    Lee, Moon-Hyoung
    Lip, Gregory Y. H.
    Joung, Boyoung
    [J]. THROMBOSIS AND HAEMOSTASIS, 2019, 119 (02) : 285 - 293
  • [30] The prothrombotic state in atrial fibrillation: pathophysiological and management implications
    Khan, Ahsan A.
    Lip, Gregory Y. H.
    [J]. CARDIOVASCULAR RESEARCH, 2019, 115 (01) : 31 - 45
12345678